Long Term Follow-Up of Drug Eluting Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Lesions

Imagem de Miniatura
Arquivos
art_YBARRA_Long_Term_Follow_Up_of_Drug_Eluting_Versus_2013.PDF (331.34 KB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
POZETTI, Antonio H.
CAMPOS, Carlos A.
LOPES, Augusto C.
ELLIS, Stephen G.
Citação
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, v.82, n.7, p.E856-E863, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: The safety and effectiveness of drug-eluting stent (DES) compared with bare metal stents (BMS) for the treatment of saphenous vein graft (SVG) disease is controversial, especially because of the lack of long-term follow-up. The aim of this study was to address the late outcome of DES versus BMS for the treatment of SVG lesions. Methods: A matched, case-control study included 82 patients in each group. Patients groups were matched by gender, age, clinical presentation, and diabetes. The primary study end point was occurrence of major adverse cardiovascular events (MACE). Secondary end points included death, cardiac death, myocardial infarction (MI), and target vessel revascularization (TVR). Results: Clinical and angiographic characteristics were similar between the groups. At 6 months, TVR (hazard ratio [HR] 6.12, 95% confidence interval [CI] 1.39 to 26.93, P = 0.05), and MACE (HR 2.54, 95% CI 1.08 to 5.98, P = 0.04) were higher in the BMS group. At 4 years the risks of MI (P = 0.21), TVR (P = 0.99), and MACE (P = 0.21) were similar between both groups. However, the rates of death (HR 2.74, 95% CI 1.11 to 6.74, P = 0.04) and cardiac death (HR 4.26, 95% CI 1.59 to 11.35, P = 0.01) were significantly higher in the BMS group. Conclusions: These results suggest that the use of DES compared with BMS in the treatment of SVG lesions reduces TVR and MACE at 6 months of follow-up, a benefit that was lost over the next 3-4 years. (C) 2012 Wiley Periodicals, Inc.
Palavras-chave
drug eluting stents, bare metal stents, saphenous vein grafts, percutaneous coronary intervention, long term follow-up
URI
https://observatorio.fm.usp.br/handle/OPI/5106
Referências
  1. Applegate RJ, 2008, CATHETER CARDIO INTE, V72, P7, DOI 10.1002/ccd.21566
  2. Assali Abid, 2008, EuroIntervention, V4, P108, DOI 10.4244/EIJV4I1A18
  3. Baldwin DE, 2010, AM J CARDIOL, V106, P946, DOI 10.1016/j.amjcard.2010.05.025
  4. BOURASSA MG, 1985, CIRCULATION, V72, P71
  5. Brilakis ES, 2011, JACC-CARDIOVASC INTE, V4, P176, DOI 10.1016/j.jcin.2010.10.003
  6. Brilakis ES, 2009, J AM COLL CARDIOL, V53, P919, DOI 10.1016/j.jacc.2008.11.029
  7. Brilakis ES, 2010, EUROINTERVENTION, V5, P722, DOI 10.4244/EIJV5I6A119
  8. Brilakis ES, 2010, JACC-CARDIOVASC INTE, V3, P1068, DOI 10.1016/j.jcin.2010.07.009
  9. Brodie BR, 2009, JACC-CARDIOVASC INTE, V2, P1105, DOI 10.1016/j.jcin.2009.08.020
  10. Brunner-La Rocca HP, 2007, EUR HEART J, V28, P719, DOI 10.1093/eurheartj/ehl490
  11. Chakravarty T, 2012, CATHETER CARDIO INTE, V79, P903, DOI 10.1002/ccd.23187
  12. Coolong A, 2008, CIRCULATION, V117, P790, DOI 10.1161/CIRCULATIONAHA.106.651232
  13. deJaegere PP, 1996, J AM COLL CARDIOL, V28, P89, DOI 10.1016/0735-1097(96)00104-0
  14. Ellis SG, 1997, AM J CARDIOL, V79, P1460
  15. FITZGIBBON GM, 1991, J AM COLL CARDIOL, V17, P1075
  16. Gioia G, 2008, CATHETER CARDIO INTE, V72, P13, DOI 10.1002/ccd.21599
  17. Hakeem A, 2011, CATHETER CARDIO INTE, V77, P343, DOI 10.1002/ccd.22720
  18. Jeger RV, 2009, CARDIOLOGY, V112, P49, DOI 10.1159/000137699
  19. Lee MS, 2011, AM J CARDIOL, V105, P1076
  20. Mehilli J, 2011, LANCET, V378, P1071, DOI 10.1016/S0140-6736(11)61255-5
  21. Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
  22. Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
  23. Nauta ST, 2012, CATHETER CARDIO INTE, V79, P912, DOI 10.1002/ccd.23145
  24. NWASOKWA ON, 1995, ANN INTERN MED, V123, P528
  25. Okabe T, 2008, AM J CARDIOL, V102, P530, DOI 10.1016/j.amjcard.2008.04.041
  26. Pucelikova T, 2008, AM J CARDIOL, V101, P63, DOI 10.1016/j.amjcard.2007.07.048
  27. Ramana RK, 2008, CATHETER CARDIO INTE, V71, P886, DOI 10.1002/ccd.21552
  28. Sanchez-Recalde A, 2010, EUROINTERVENTION, V6, P149, DOI 10.4244/
  29. Savage MP, 1997, NEW ENGL J MED, V337, P740, DOI 10.1056/NEJM199709113371103
  30. Singh M, 2005, AM J CARDIOL, V96, P907, DOI 10.1016/j.amjcard.2005.05.045
  31. Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
  32. Testa L, 2010, EUROINTERVENTION, V6, P527, DOI 10.4244/EIJ30V6I4A87
  33. van Twisk Piet-Hein, 2008, EuroIntervention, V4, P311, DOI 10.4244/EIJV4I3A57
  34. Vermeersch P, 2006, J AM COLL CARDIOL, V48, P2423, DOI 10.1016/j.jacc.2006.09.021
  35. Vermeersch P, 2007, J AM COLL CARDIOL, V50, P261, DOI 10.1016/j.jacc.2007.05.010
  36. Vignali L, 2008, AM J CARDIOL, V101, P947, DOI 10.1016/j.amjcard.2007.11.055
  37. Wiisanen ME, 2010, JACC-CARDIOVASC INTE, V3, P1262, DOI 10.1016/j.jcin.2010.08.019

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - ODS/03